Journal: Nature Microbiology
Article Title: Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function
doi: 10.1038/s41564-024-01838-z
Figure Lengend Snippet: a , Primary human cardiomyocytes were incubated for 24 h (top row) and 48 h (bottom row) with media alone ((RPMI-1640/B27 with insulin; control) or a cocktail of IL-12, IL-1β, MCP-1 and IL-6 (‘cytokines’). Cytokine concentrations were either ‘Recovered cytokine mimic’ (IL-12, 0.007 fg ml −1 ; IL-1β, 0.01 fg ml −1 ; MCP-1, 0.01 fg ml −1 ; IL-6, 0.004 fg ml −1 ) or ‘PASC-CVS cytokine mimic’ (IL-12, 41 fg ml −1 ; IL-1β, 21 fg ml −1 ; MCP-1, 14 fg ml −1 ; IL-6, 21 fg ml −1 ) to reflect levels detected in the PASC-CVS cohorts. Data are pooled from two independent experiments. Graphs show mean ± s.e.m. Normal distribution of data was assessed with the Shapiro–Wilk test. Statistical significance was determined with a Kruskal–Wallis test with Dunn’s multiple comparison test or Welch ANOVA test and Dunnett’s multiple comparison test. b , Primary human cardiomyocytes were incubated for 24 h (top row) and 48 h (bottom row) with PASC-CVS or Recovered plasma. Data are displayed relative to cardiomyocytes treated with media alone. Mean ± s.e.m. is shown in all graphs. Statistical significance was determined with an ANCOVA adjusted for age, sex and/or site as covariates. Covariates were included in the analysis if statistically significant difference in the covariate was recorded between groups. Each donor is indicated by a unique symbol that is used consistently throughout all figures. Grey horizontal lines indicate the mean value derived from n = 22 Healthy donors. A description of the Healthy donor cohort is presented in Supplementary Table .
Article Snippet: Surface-enhanced Raman scattering nanotags were conjugated with antibodies against IL-1β (MAB601, clone 2805), IL-6 (AF-206, polyclonal), IL-12p70 (MAB611, clone 24945), IL-12p70 (MAB219, clone 24910) or MCP-1 (MAB679, clone 23007) obtained from R&D Systems.
Techniques: Incubation, Control, Comparison, Clinical Proteomics, Derivative Assay